Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sibutramine plus Diet in PCOS
NCT00463112Phase 4Completed
- Sponsor
- Hippocration General Hospital
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sibutramine in polycystic ovary syndrome (PCOS) and obesity (2 arms), sponsored by Hippocration General Hospital. Primary endpoint: Weight loss at 6 months. Started Mar 2004; status: completed.
02
Drugs
sibutramine
03
Conditions
polycystic ovary syndrome (PCOS)obesity
Beyond the preview
Go deeper on NCT00463112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463112.